Tag

PMWS24

Peter Shearstone of Thermo Fisher Scientific — Changing the Compliance Paradigm in Large, Global Companies
LIFE SCIENCES, VIDEO, LIFE SCIENCES, PODCAST

Peter Shearstone of Thermo Fisher Scientific — Changing the Compliance Paradigm in Large, Global Companies

As part of the 2024 edition of the Pharma Manufacturing World Summit we interviewed Peter Shearstone, Thermo Fisher Scientific’s VP Global Quality & Regulatory Affairs, about a themed lunch discussion he hosted that revolved around Compliance in the pharmaceutical space, especially as it related to companies with a worldwide footprint. How does Compliance shape the way businesses function? How is that changing over time? How did the pandemic change the way the pharmaceutical industry thinks about itself and problem-solves? What can large organizations learn from the capabilities and outlook of smaller and more nimble companies? What are the things global companies will always do well, but can still do better? What should every leader working in this space be thinking about and learning about and doing more of to improve themselves, their teams, and the industry as a whole? For all this and more, give this episode a listen!

Continue reading
Alarm Management and What Pharmaceutical Manufacturers Need to Know — A Conversation with Michael Andrews of Applied Materials
LIFE SCIENCES, VIDEO, LIFE SCIENCES, PODCAST

Alarm Management and What Pharmaceutical Manufacturers Need to Know — A Conversation with Michael Andrews of Applied Materials

At the 2024 edition of the Pharma Manufacturing World Summit held earlier this month in Boston, we spoke with Michael Andrews, the Global Product Manager | SmartFactory Rx® of Applied Materials, to talk about an important issue facing pharmaceutical manufacturers and how the experience of the semiconductor industry can help: Alarm Management.

In most manufacturing facilities, an alert, an alarm, a warning, or a notice is going off somewhere every few seconds. Different machines inform different operators of different data. Very few manufacturers have a clear overview of what is being flagged everywhere at any one time, and the human operators who work with their systems day in and day out quickly learn to ignore some alarms while perhaps putting too much time and attention into monitoring others. Would it not be to everyone’s advantage to have an overarching system that brings all alarms up to the same level of visibility and then helps human operators recognize which ones to focus on at any one time? As luck would have it, the ever-evolving semiconductor manufacturing space has already created a system that operates in an even more fast-paced and exacting manufacturing environment than the one most pharmaceutical companies operate in, and Applied Materials is helping taking the hard-won lessons of Alarm Management from that industry and bringing it to the tightly regulated, patient-focused, quality-centric pharmaceutical manufacturing space. For every pharmaceutical executive who worries things are getting missed in their manufacturing facilities, give this episode a listen!

Continue reading
Issues, Trends, Excitement, and Great News for Pharmaceutical Manufacturers — A Conversation with Teresa Gorecki of Compliance Architects
LIFE SCIENCES, VIDEO, LIFE SCIENCES, PODCAST

Issues, Trends, Excitement, and Great News for Pharmaceutical Manufacturers — A Conversation with Teresa Gorecki of Compliance Architects

At the 2024 edition of the Pharma Manufacturing World Summit we sat down with Teresa Gorecki of Compliance Architects to speak with enthusiasm and optimism about the future of medicine, the most recent developments and what they mean for patients, but especially the most recent ideas and information pharmaceutical manufacturers and other senior leaders in the Life Sciences need to know as the industry moves forward together into a very exciting time. What are some of the top-of-mind challenges and opportunities pharma manufacturers are dealing with right now, and how are the early adaptors already addressing those issues? How are regulators working with industry to improve end results for patients? How is commercialization of ATMPs progressing, and what can we all learn from the first examples coming online now? For all this and more, give this episode a listen!

Continue reading